ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Chabner Says Vials DCT Obtained From Burton Operation Were Contaminated

June 8, 1984

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Scope Of Panel’s Inquiry Outlined In Letter To Members

July 22, 1994

DCE Board Sets Aside $2 Million For Radiation Grants Program; Okays Concept For Add-On To ASCUS Trial

October 13, 1995

USC $2.5 Million contract Tops Last Minute FY 75 Rush of Awards

July 18, 1975

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993